Botanical species · safety record

Delphinium elatum

The EFSA Compendium of Botanicals holds 17 constituent measurements for Delphinium elatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Delphinium elatum L.

17Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Ajaconine	Seed	Solvent extraction	0.0215 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Delectinine	Seed	Solvent extraction	0.003 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Delpheline	Seed	Solvent extraction	0.016 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Diterpene alkaloids	Roots and other underground parts	Solvent extraction	≥ 2.24 Percent	—	Resolve DOI
Diterpene alkaloids	Roots and other underground parts	Solvent extraction	≤ 2.5 Percent	—	Resolve DOI
Elanine	Seed	Solvent extraction	0.009 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lycoctonine	Seed	Solvent extraction	0.01 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Norditerpene alkaloids	Seed	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Nudicauline	Roots and other underground parts	Solvent extraction	2.27 Percent	—	Resolve DOI
Pacinine	Seed	Solvent extraction	0.0067 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Delectinine	Aerial part of plants	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Delpheline	Seed	Solvent extraction	0.092 Percent	Physical tests	No resolvable identifier
Eladine	Seed	Solvent extraction	0.009 Percent	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Elasine	Seed	Solvent extraction	0.009 Percent	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Elatine	—	—	—	—	No resolvable identifier
Methyllycaconitine	Seed	Solvent extraction	—	Physical tests	No resolvable identifier
Nudicauline	Aerial part of plants	Solvent extraction	—	Chromatographic tests	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

PELLETIER, SW., ROSS, SA., DESAI, HK. A NORDITERPENOID ALKALOID FROM DELPHINIUM-ELATUM. PHYTOCHEMISTRY, 1990, vol. 29, no. 7, p. 2381-2383. DOI
Bessonova, IA., Saidkhodzhaeva, SA. Alkaloids of Delphinium elatum cultivated plants. KHIMIYA PRIRODNYKH SOEDINENII, 1998, no. 2, p. 245-246.
Goodson, J.A. The alkaloids of the seeds of delphinium elatum, L.. Journal of the Chemical Society (Resumed), 1943, p. 139-141.
Samusenko, L.N., Razakova, D.M., Bessonova, I.A., Gorelova, A.P. Alkaloids of the cultivated species Aconitum chasmanthum and Delphinium elatum. Chemistry of Natural Compounds, 1992, vol. 28, no. 1, p. 125-126. DOI
Dozortseva, P. M. Elatin. Meditsinskaya Promyshlennost SSSR, 1956, p. 31-32.
PELLETIER, SW., ROSS, SA., KULANTHAIVEL, P. NEW ALKALOIDS FROM DELPHINIUM-ELATUM L. TETRAHEDRON, 1989, vol. 45, no. 7, p. 1887-1892.
Wada, Koji., Chiba, Ryota., Kanazawa, Rina., Matsuoka, Kei., Suzuki, Miyako., Ikuta, Midori., Goto, Masuo., Yamashita, Hiroshi., Lee, Kuo-Hsiung. Six new norditerpenoid alkaloids from Delphinium elatum. PHYTOCHEMISTRY LETTERS, 2015, vol. 12, p. 79-83. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature